BANGALORE: Lack of a proper regulatory framework and other hurdles of Bio-Technology industry stole the spotlight at the inauguration of Bangalore India Bio 2012 in the city on Monday. Speaking at the inaugural session of the three-day conference, BioCon managing director and chairperson of Karnataka Vision Group on BT, Kiran Mazumdar Shaw said, “There are unrealistic expectations from us. Only a proper regulatory framework would help in realising these expectations.” She added that the regulatory system was quintessential in providing support for innovation in Bio-Technology.
M K Bhan, secretary, Department of IT/BT and Science and Technology, GOI, said there was only one set of regulations for both Pharma and Bio Industry.
“The BT industry is more complex and we can’t apply the existing regulations for both,” he said.
He added that he hoped the long pending National Biotechnology Regulatory Authority of India (NBRAI) Bill, which is in the Parliament would be passed through soon. “A task force would be formed soon, which would have representation from private sector, multinational companies and domestic industries,” said Union Minister for Health and Family welfare, Ghulam Nabi Azad.
He also called for industry leaders to make their recommendations to the task force to ensure the regulations are better laid. Azad also said that the government aimed at improving regulations in the BT system.